Franco M. Venanzi
Senior Researcher Professor of Physiology, Group Leader Unit of Translational Biology
University of Camerino, Italy
Franco Maria Venanzi, PhD, is a research professor of Physiology at the University of Camerino (UNICAM) Italy, where is Head of the Laboratory of Translational Biology Laboratory. His research is in the area of cancer vaccines and cancer immunotherapy. Since the mid-90s his research is aimed at developing DNA-based vaccines to treat cancer (e.g. breast cancer and melanoma). He pioneered the development of DNA vaccines against the oncogene HER-2/neu, and his preclinical studies contributed to the progression of the vaccine to the clinical setting. Since the work began he has sought to develop new approaches to further increase the potency of DNA vaccines using immune-stimulatory gene adjuvants. Recently, Prof. Venanzi scientific interest extended to the search of predictive biological markers to enable the selection of cancer patients who are most likely to benefit from dendritic cells-based immunotherapy. Prof. Venanzi serves as reviewer for various journal of oncology and immunology and as scientific consultant for small biotech companies.
DNA vaccines, Cancer Vaccines